Efficacy and Safety of HE10 for Dry Eye Syndrome
NCT02492412 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2015-07-08
Summary
The purpose of this study is to evaluate the efficacy and safety of HE10 eye drop for the patients with moderate to severe dry eye syndrome.
Conditions
- Dry Eye Syndrome
Interventions
- DRUG
-
HE 10
- DRUG
-
Restasis
Sponsors & Collaborators
-
Huons Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2014-07-31
- Completion
- 2014-09-30
More Related Trials
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT03211351 ·Status: COMPLETED ·Phase: NA
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
NCT05109702 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye
NCT06517667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION
NCT02470429 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye Syndromes
NCT01804361 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
NCT02522312 ·Status: COMPLETED
-
Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients
NCT04127851 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction
NCT05159284 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
NCT01427816 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01890941 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects
NCT05219461 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax
NCT04555694 ·Status: COMPLETED ·Phase: PHASE4
-
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
NCT03597139 ·Status: COMPLETED ·Phase: PHASE2
-
ACCURATE Study for Subjects With Dry Eyes
NCT04237012 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Eye Treatment With Artificial Tears
NCT02420834 ·Status: COMPLETED ·Phase: NA